Kishimoto, T., Kojima, Y., & Fujimoto, N. (2021). Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion. Nature Portfolio.
Cita Chicago Style (17a ed.)Kishimoto, Takumi, Yoko Kojima, y Nobukazu Fujimoto. Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion. Nature Portfolio, 2021.
Cita MLA (8a ed.)Kishimoto, Takumi, et al. Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.